| Předmět: |
|
| Zdroj: |
Vaccine Weekly; 1/8/2024, p825-825, 1p |
| Abstrakt: |
A recent study conducted at Massachusetts General Hospital found that single-dose human papillomavirus (HPV) vaccination was highly effective and safe in young Kenyan women. The study, which followed participants for three years, showed that the vaccine had a high efficacy rate against persistent HPV infection. The results indicated that the vaccine provided durable protection without any severe adverse events. This research provides valuable insights into the effectiveness of HPV vaccination in populations with low vaccination and screening coverage for cervical cancer. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
